Statera Biopharma, Inc. Quarterly Other Assets, Current in USD from Q4 2010 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Statera Biopharma, Inc. quarterly Other Assets, Current history and growth rate from Q4 2010 to Q3 2022.
  • Statera Biopharma, Inc. Other Assets, Current for the quarter ending September 30, 2022 was $248K, a 76.2% decline year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $248K -$797K -76.2% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $290K +$243K +519% Jun 30, 2022 10-Q 2022-10-28
Q1 2022 $325K +$254K +363% Mar 31, 2022 10-Q 2022-10-21
Q4 2021 $837K +$835K +32776% Dec 31, 2021 10-Q 2022-11-14
Q3 2021 $1.05M +$990K +1805% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $46.8K -$9.93K -17.5% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $70.1K -$9.91K -12.4% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 $2.55K -$42.8K -94.4% Dec 31, 2020 10-K 2022-10-06
Q3 2020 $54.9K -$12.7K -18.8% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $56.8K -$17.9K -24% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $80K -$35.8K -30.9% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $45.4K -$58K -56.1% Dec 31, 2019 10-K 2021-03-22
Q3 2019 $67.6K -$37.1K -35.5% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $74.6K -$46.9K -38.6% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $116K -$136K -54% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 $103K -$130K -55.7% Dec 31, 2018 10-K 2020-04-15
Q3 2018 $105K -$216K -67.4% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 $122K -$171K -58.5% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 $252K +$20.6K +8.92% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 $234K -$56.2K -19.4% Dec 31, 2017 10-K 2019-03-07
Q3 2017 $321K -$283K -46.8% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 $293K -$294K -50.1% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 $231K -$269K -53.8% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 $290K -$153K -34.5% Dec 31, 2016 10-K 2018-03-06
Q3 2016 $604K +$98.2K +19.4% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 $587K +$371K +172% Jun 30, 2016 10-Q 2016-08-15
Q1 2016 $500K +$251K +101% Mar 31, 2016 10-Q 2016-05-16
Q4 2015 $443K +$268K +154% Dec 31, 2015 10-K 2017-02-22
Q3 2015 $506K +$140K +38.3% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $216K -$262K -54.8% Jun 30, 2015 10-Q 2015-08-12
Q1 2015 $249K -$129K -34.1% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 $174K -$170K -49.4% Dec 31, 2014 10-K 2016-02-23
Q3 2014 $365K -$225K -38.1% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 $477K -$253K -34.6% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 $377K -$759K -66.8% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 $344K -$734K -68.1% Dec 31, 2013 10-K 2015-02-27
Q3 2013 $591K -$730K -55.3% Sep 30, 2013 10-Q 2013-11-08
Q2 2013 $730K -$594K -44.9% Jun 30, 2013 10-Q 2013-08-09
Q1 2013 $1.14M +$354K +45.3% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 $1.08M +$201K +22.9% Dec 31, 2012 10-K 2014-03-17
Q3 2012 $1.32M +$358K +37.2% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 $1.32M +$115K +9.49% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 $782K Mar 31, 2012 10-Q 2012-05-07
Q4 2011 $877K -$114K -11.5% Dec 31, 2011 10-K 2013-03-18
Q3 2011 $963K Sep 30, 2011 10-Q/A 2011-11-14
Q2 2011 $1.21M Jun 30, 2011 10-Q 2011-08-09
Q4 2010 $991K Dec 31, 2010 10-K 2012-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.